Beta-thalassemia: renal complications and mechanisms: a narrative review
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in Hematology
- Vol. 24 (1) , 426-438
Abstract
Objectives: Beta-thalassemias are a group of recessively autosomal inherited disorders of hemoglobin synthesis, which, due to mutations of the beta-globin gene, lead to various degrees of defective beta-chain production, an imbalance in alpha/beta-globin chain synthesis, ineffective erythropoiesis, and anemia. Improved survival in thalassemic patients has led to the emergence of previously unrecognized complications, such as renal disease. Methods: A comprehensive literature review through PubMed was undertaken to summarize the published evidence on the epidemiology and pathophysiology of renal disease in thalassemia. Literature sources published in English since 1990 were searched, using the terms beta-thalassemia, renal disease. Results: Renal disease is considered to be the 4th cause of morbidity among patients with transfusion dependent thalassemia. Chronic anemia, hypoxia and iron overload are the main mechanisms implicated in development of renal injury, whereas several studies also suggested a contributive role of iron chelators. Discussion and Conclusion: Kidney disease may develop through progressive renal tubular and glomerular damage; thus, its early recognition is important in order to prevent and/or reverse deterioration. This review will provide an insight on the involved mechanisms implicated in kidney disease in thalassemic patients and will discuss the updates on diagnosis and prevention of renal complications in thalassemia.Keywords
This publication has 90 references indexed in Scilit:
- Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or IntermediaOman Medical Journal, 2013
- Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: A retrospective studyBlood Cells, Molecules, and Diseases, 2012
- β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolismBlood, 2011
- Iron-Chelating Therapy for Transfusional Iron OverloadNew England Journal of Medicine, 2011
- The inherited diseases of hemoglobin are an emerging global health burdenBlood, 2010
- Renal Functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective studyItalian Journal of Pediatrics, 2010
- Specific iron chelators determine the route of ferritin degradationBlood, 2009
- Renal tubule function in beta-thalassemia after hematopoietic stem cell transplantationPediatric Nephrology, 2009
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Iron-deficiency anaemia enhances red blood cell oxidative stressFree Radical Research, 2008